BioInvent Financial Statements From 2010 to 2025
| BINV Stock | SEK 31.60 0.20 0.64% |
Check BioInvent International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioInvent International's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioInvent financial statements analysis is a perfect complement when working with BioInvent International Valuation or Volatility modules.
BioInvent |
BioInvent International AB Company Operating Margin Analysis
BioInvent International's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BioInvent International Operating Margin | (0.16) % |
Most of BioInvent International's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioInvent International AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, BioInvent International AB has an Operating Margin of -0.1621%. This is 99.54% lower than that of the Biotechnology sector and 99.86% lower than that of the Health Care industry. The operating margin for all Sweden stocks is 97.06% lower than that of the firm.
BioInvent International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioInvent International's current stock value. Our valuation model uses many indicators to compare BioInvent International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioInvent International competition to find correlations between indicators driving BioInvent International's intrinsic value. More Info.BioInvent International AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioInvent International's earnings, one of the primary drivers of an investment's value.About BioInvent International Financial Statements
BioInvent International shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioInvent International investors may analyze each financial statement separately, they are all interrelated. The changes in BioInvent International's assets and liabilities, for example, are also reflected in the revenues and expenses on on BioInvent International's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.